-
Innovation Ranking
Innovation Ranking – Acadia Pharmaceuticals Inc
Acadia Pharmaceuticals Inc (Acadia) discovers, develops, and commercializes small molecule drugs for the treatment of central nervous system (CNS) disorders. The company’s marketed product Nuplazid (pimavanserin) is an FDA-approved drug for the treatment of Parkinson’s disease psychosis. It's pipeline includes pimavanserin for the treatment of various indications which include Schizophrenia, Major Depressive Disorder (MDD), dementia-related psychosis (DRP), and trofinetide for the treatment of Rett Syndrome. The company markets its product in the US. It has operational presence in Denmark, Switzerland,...
-
Product Insights
Acadia Healthcare/ Orlando Health – Apopka Behavioral Health Services Facility – Florida
The Acadia Healthcare/ Orlando Health – Apopka Behavioral Health Services Facility – Florida involves the construction of a two-story 9,290m2 behavioral health services facility comprising 144 beds in Apopka, Florida, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Acadia Healthcare/ Orlando Health – Apopka Behavioral Health Services Facility – Florida report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pimavanserin Tartrate in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pimavanserin Tartrate in Autism Spectrum Disorder (ASD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pimavanserin Tartrate in Autism Spectrum Disorder (ASD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NNZ-2591 in Rett Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NNZ-2591 in Rett Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NNZ-2591 in Rett Syndrome Drug Details: NNZ-2591 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Synovial Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Synovial Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Synovial Sarcoma Drug Details: Selinexor (Xpovio, Nexpovio) is an...
-
Product Insights
Acadia Power Station
Acadia Power Station is a thermal project located in Louisiana, United States. The project is owned by Cleco Power LLC; Entergy Louisiana LLC. The project came online in 2002. Empower your strategies with our Acadia Power Station report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
NewNet Present Value Model: Acadia Pharmaceuticals Inc’s Trofinetide
Empower your strategies with our Net Present Value Model: Acadia Pharmaceuticals Inc's Trofinetide report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-204 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-204 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-204 in Alzheimer's Disease Drug Details: ACP-204 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-204 in Psychosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-204 in Psychosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-204 in Psychosis Drug Details: ACP-204 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pimavanserin Tartrate in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pimavanserin Tartrate in Schizophrenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pimavanserin Tartrate in Schizophrenia Drug Details: Pimavanserin tartrate (Nuplazid) is a phenol...